(Reuters) – Five drugmakers and distributors are offering $22 billion in cash as well as drugs and services they value at $28 billion to resolve lawsuits alleging the industry helped fuel the U.S. opioid crisis, two sources familiar with the matter told Reuters on Wednesday.
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference hold by its CEO, Kare Schultz, to discuss the company’s 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen
The drug industry faces roughly 2,600 lawsuits brought by state and local governments, hospitals and other entities seeking to hold drugmakers and distributors responsible for the toll of opioid abuse. Local governments seek funds to cover costs of services in their communities.
Distributors McKesson Corp (MCK.N), AmerisourceBergen Corp (ABC.N) and Cardinal Health (CAH.N) have offered to pay $18 billion in cash over 18 years, while drug maker Johnson & Johnson (JNJ.N) would pay $4 billion in cash, two people familiar with the matter said.
Teva Pharmaceutical Industries Ltd (TEVA.TA) has offered to give away medications it values at $15 billion as part of the deal and provide distribution services it values in the billions, one of the people said.
Both said that Teva’s proposed agreement would run over 10 years and had a total estimated value of around $28 billion. However, it is not clear how the valuation was reached, and one source said some states are asking whether Teva should pay cash as well.
The negotiations are being led by the attorneys general for Texas, Tennessee, North Carolina and Pennsylvania, one person said.
Teva and the three distributors are all defendants in a landmark trial set to begin in federal court in Cleveland, Ohio, on Monday. U.S. District Judge Dan Polster, who has long pushed for a global settlement of the litigation, will preside over the trial.
The distributors, accused of failing to halt and report suspicious drug orders, are pushing for a settlement to be agreed to before the trial begins Monday, one source said. The second source added that a sticking point was compensation for lawyers who typically are paid a percentage of settlements and represent many of the state and local plaintiffs.
The sources cautioned that there was no guarantee a deal would be struck. One source said lawyers for the thousands of cities and counties with cases pending in federal court have not yet agreed to back the proposal the states are negotiating.
Opioid addiction claimed roughly 400,000 lives in the United States from 1999 to 2017, according to the U.S. Centers for Disease Control and Prevention.
The companies did not respond to requests for comment on Wednesday. J&J on Tuesday had said it was open to a settlement.
Reporting by Tamara Mathias in Bengaluru and Nate Raymond in Boston; Editing by Peter Henderson, Shinjini Ganguli and Cynthia Osterman
more recommended stories
U.S. watchdog backs Bezos’ protest over key Pentagon launch program
WASHINGTON (Reuters) – A U.S. watchdog.
Boeing to give Southwest board 737 MAX update this week
CHICAGO (Reuters) – Boeing Co (BA.N).
Asia shares in waiting mode ahead of Fed, ECB events
SYDNEY (Reuters) – Asian share markets.
Alibaba’s Hong Kong listing offers valuable Beijing goodwill
SHANGHAI (Reuters) – Alibaba’s Hong Kong.
Warren proposes ‘corporate perjury’ law related to industry-funded research
WASHINGTON (Reuters) – U.S. Senator Elizabeth.
Dollar, stocks slip amid trade deal uncertainty
NEW YORK (Reuters) – The dollar.
Adidas to close German, U.S. robot factories
FILE PHOTO: Prototypes of Futurecraft 3D.
EasyJet buys Thomas Cook airport slots at Gatwick and Bristol for $46 million
FILE PHOTO: Passengers board an easyJet.
LafargeHolcim says takes note of French court decision on Syria
FILE PHOTO: The logo of LafargeHolcim,.
Acting UAW head to examine ‘every inch’ of union in scandal’s wake
DETROIT (Reuters) – The acting head.